Share/Bookmark Find us on Facebook
  • 5-17-2012

UMDNJ-The University Hospital First to Use Pipeline Stents
in Northern New Jersey

Procedure used to treat rare, complex brain aneurysms


(Newark, NJ)  
UMDNJ-The University Hospital is the first hospital in northern New Jersey to use the Pipeline™ Embolization Device, referred to as a pipeline stent, to treat rare, complex brain aneurysms.  The hospital successfully used the pipeline stents for two patients on April 24.

 

“The pipeline stents are used for aneurysms that are difficult to treat due to their size and location,” said the leader of the two surgeries, Chirag D. Gandhi, MD, assistant professor of neurosurgery and radiology, and director of the endovascular neurosurgery fellowship at University of Medicine and Dentistry of New Jersey (UMDNJ)-New Jersey Medical School. “This procedure will make it less likely that the aneurysms will reoccur.”


According to Dr. Gandhi, these flow-diverting, intracranial pipeline stents are FDA approved. They are manufactured by Covidien, a leading global healthcare products company that manufactures, distributes and services a diverse range of industry-leading product lines in three segments: medical devices, pharmaceuticals and medical supplies.  The company describes the Pipeline™ Embolization Device as a tube of wire delivered to brain aneurysms via a catheter.  It is designed to encourage the aneurysm to clot off and reduce pressure on the surrounding brain.

 

Interviews with Dr. Gandhi, as well as with patients who received the pipeline stents, may be arranged by calling Tiffany L. Smith at 973-972-1025.


UMDNJ-The University Hospital is one of the United States' leading university medical centers and the principal teaching hospital for University of Medicine and Dentistry of New Jersey (UMDNJ)-New Jersey Medical School (NJMS). Located in the Central Ward of Newark, the hospital offers the highest quality of care across many medical specialties.

 

The Department of Neurological Surgery at New Jersey Medical School has been part of the Neurological Institute of New Jersey since its founding in 1995.  The department is a world leader in neurosurgery and was recently recognized with the 2012 HealthGrades Neurosurgery Excellence Award.  The faculty has been awarded numerous Top Doctor recognitions, and the hospitals those physicians serve were rated #1 in New Jersey for Neurological Disorders, as well as among the Top Hospitals for Neurological Disorders and Stroke Care by Castle Connolly Guide.  The faculty provides a wide range of care for neurological disorders and is one of the most highly published academic departments in the United States.


The University of Medicine and Dentistry of New Jersey (UMDNJ) is New Jersey’s only health sciences university with more than 6,000 students on five campuses attending the state's three medical schools, its only dental school, a graduate school of biomedical sciences, a school of health related professions, a school of nursing and New Jersey’s only school of public health. UMDNJ operates University Hospital, a Level I Trauma Center in Newark, and University Behavioral HealthCare, which provides a continuum of healthcare services with multiple locations throughout the state.